Cardiac re-transplantation in pediatrics: a multi-institutional study

Area of Science:

• Pediatric Cardiology
• Transplantation Medicine
• Immunology

Background:

• Pediatric cardiac re-transplantation (re-Tx) is a complex procedure with debated outcomes.
• Investigating re-Tx incidence, risk factors, and outcomes in children is crucial for improving care.
• The Pediatric Heart Transplant Study (PHTS) database provides valuable data for this analysis.

Purpose of the Study:

• To determine the incidence of cardiac re-transplantation in pediatric recipients.
• To identify risk factors associated with the need for re-Tx in children.
• To analyze patient survival and outcomes following pediatric cardiac re-Tx.

Main Methods:

• Utilized the PHTS database, including pediatric subjects (
• Employed multivariate analyses in the hazard-function domain to identify risk factors for re-Tx and mortality.
• Compared survival rates after re-Tx with those after primary transplantation (PTx).

Main Results:

• Identified ventilator support, African-American ethnicity, and elevated creatinine as risk factors for re-Tx.
• Observed inferior patient survival after re-Tx compared to PTx (1-, 3-, and 5-year survival: 80%, 69%, 60%).
• Found that re-Tx for graft coronary artery disease had better outcomes than for early graft failure; early graft failure and rejection during PTx were key risk factors for death after re-Tx.

Conclusions:

• Survival following pediatric cardiac re-Tx is significantly lower than after primary transplantation.
• Re-transplantation for early graft failure and rejection present high mortality risks and may be contraindicated.
• Re-Tx appears acceptable for pediatric patients surviving at least one year post-PTx, particularly those with graft coronary artery disease.